Back
Header image

Transforming Global Genetic Data into Medical Decisions

Our goal is the rapid medical diagnosis of inherited diseases, provided at the earliest possible moment as we turn analytical information into actionable results for physicians, patients and pharmaceutical partners.

Our commitment to the global medical community is an early and precise diagnosis for continuous improvement of therapeutic options for each individual patient.

Latest Scientific News

Genotype Phenotype Correlation in a New Fabry-Disease-Causing Mutation

The interpretation of missense variants in a disease context is challenging, especially…

Article with topic Biomarker, Metabolism, Cardiology
Read more

A hexanucleotide repeat modifies expressivity of X-linked dystonia…

Disease expressivity varies widely in many genetic disorders, and identifying the…

Article with topic Neurology
Read more

Identification of PKD1 and PKD2 gene variants in a cohort of 125 Asian…

CENTOGENE considers its global positioning a key aspect for generating truly novel…

Article with topic Nephrology and endocrinology
Read more

A homozygous frameshift variant in an alternatively spliced exon of DLG5…

Based on the ambition to provide maximum diagnostic yield, CENTOGENE offers follow up of…

Article with topic WES, WGS, Neurology
Read more

Customer Feedback

Give feedback

Newsletter subscription

CENTOGENE Welcomes Germany’s Chancellor Dr. Angela Merkel

 CENTOGENE today welcomed Germany’s Chancellor Dr. Angela Merkel to its headquarters together with Manuela Schwesig, Minister-President of...

 Read more
Centogene,

Presse-Einladung anlässlich des Besuches der Bundeskanzlerin, Dr. Angela Merkel, am 23. Mai 2019

Digitalisierung - was braucht das Land und was braucht die Wirtschaft am Beispiel einer Erfolgsgeschichte der Branche Gesundheitswirtschaft

Read more
Centogene,

CENTOGENE Appoints AI Industry Leader Dr. Carsten Ullrich as Director of Artificial Intelligence

Research Fellow from German Research Center for Artificial Intelligence to lead team driving solutions for pharmaceutical partners.

 Read more
Centogene,

CentoMetabolic™ Panel for Integrated Multiomic Testing for Metabolic Diseases

Combining genetic and biochemical testing to provide the most comprehensive screening for rare metabolic conditions.

 Read more
Centogene,

CENTOGENE announces the appointment of Dr. Flemming Ornskov to the Supervisory Board as Non-Executive Chairman

CENTOGENE announced today that Dr. Flemming Ornskov has been appointed to the Supervisory Board and has been elected Non-Executive Chairman.  His appointment is...

 Read more
Centogene,

Digitization in Mecklenburg-Vorpommern

As part of an exchange with senior business and academic leaders, and state of Mecklenburg-Vorpommern (M-V) government representatives, a discussion and...

 Read more
Centogene,

CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics

Agreement focused on identification of patients with Duchenne muscular dystrophy (DMD)

 Read more
Centogene,

New Validation Framework to Optimize Specificity and Sensitivity in WES-Based Diagnostics

CENTOGENE, a rare disease company committed to improving the lives of rare disease patients by providing solutions that accelerate the development of drugs, has...

 Read more
Centogene,

CENTOGENE Expands Clinical Studies Team in U.S.

Driving Pharmaceutical Partnerships and Accelerating Orphan Drug Development

 Read more
Centogene,